Growth Metrics

Vanda Pharmaceuticals (VNDA) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.40%
Dec 31, 2025 -25.49%
Sep 30, 2025 -6.82%
Jun 30, 2025 -4.09%
Mar 31, 2025 -3.18%
Dec 31, 2024 1.20%
Sep 30, 2024 0.55%
Jun 30, 2024 1.51%
Mar 31, 2024 1.26%
Dec 31, 2023 2.24%
Sep 30, 2023 3.19%
Jun 30, 2023 5.35%
Mar 31, 2023 6.79%
Dec 31, 2022 6.81%
Sep 30, 2022 7.25%
Jun 30, 2022 7.30%
Mar 31, 2022 11.11%
Dec 31, 2021 11.31%
Sep 30, 2021 12.38%
Jun 30, 2021 12.04%
Mar 31, 2021 11.19%
Dec 31, 2020 10.28%
Sep 30, 2020 8.74%
Jun 30, 2020 36.01%
Mar 31, 2020 39.12%
Dec 31, 2019 45.65%
Sep 30, 2019 52.10%
Jun 30, 2019 22.96%
Mar 31, 2019 10.67%
Dec 31, 2018 61.68%
Sep 30, 2018 51.64%
Jun 30, 2018 43.79%
Mar 31, 2018 55.00%
Dec 31, 2017 -2.35%
Sep 30, 2017 -1.31%
Jun 30, 2017 4.27%
Mar 31, 2017 -0.98%
Dec 31, 2016 -1.26%
Sep 30, 2016 -5.49%
Jun 30, 2016 -9.68%
Mar 31, 2016 -3.23%
Dec 31, 2015 24.08%
Sep 30, 2015 178.55%
Jun 30, 2015 159.59%
Mar 31, 2015 76.59%
Dec 31, 2014 19.78%
Sep 30, 2014 -48.95%
Jun 30, 2014 -26.32%
Mar 31, 2014 -3.32%
Dec 31, 2013 5.83%
Sep 30, 2013 3.53%
Jun 30, 2013 -27.28%
Mar 31, 2013 -27.50%
Dec 31, 2012 -25.83%
Sep 30, 2012 -23.47%
Jun 30, 2012 -20.94%
Dec 31, 2011 -14.30%